Unicharm (OTCMKTS:UNICY - Get Free Report) was the recipient of a large decrease in short interest in the month of August. As of August 15th, there was short interest totaling 11,000 shares, adecreaseof75.3% from the July 31st total of 44,600 shares. Based on an average trading volume of 2,762,700 shares, the short-interest ratio is presently 0.0 days. Based on an average trading volume of 2,762,700 shares, the short-interest ratio is presently 0.0 days.
Unicharm Stock Performance
UNICY traded down $0.02 during trading hours on Friday, hitting $3.30. The stock had a trading volume of 301,887 shares, compared to its average volume of 751,513. The company's fifty day simple moving average is $3.43 and its 200 day simple moving average is $3.85. Unicharm has a 1 year low of $3.06 and a 1 year high of $8.10. The stock has a market cap of $11.57 billion, a PE ratio of 16.51 and a beta of 0.22. The company has a quick ratio of 1.87, a current ratio of 2.32 and a debt-to-equity ratio of 0.01.
Unicharm (OTCMKTS:UNICY - Get Free Report) last announced its quarterly earnings data on Tuesday, August 5th. The company reported $0.03 earnings per share for the quarter. The firm had revenue of $1.64 billion during the quarter, compared to analysts' expectations of $1.81 billion. Equities analysts anticipate that Unicharm will post 0.17 earnings per share for the current year.
Unicharm Company Profile
(
Get Free Report)
Unicharm Corporation engages in the manufacturing and sale of wellness, feminine, baby and children, kirei, and pet care products in Japan and internationally. The company's baby and child care products, including disposable diapers and wipes under the Moony, MamyPoko, Oyasumiman, and Torepanman brands; feminine care products comprise napkins, tampons, panty liners, sanitary short, panty liners, and other feminine care products under the Sofy, Center-In, and Unicharm brand names; and wellness care products include napkin-type incontinence pads, pants-type diapers, tape-type diapers, pants-type specialized urine pads, and tape-type specialized urine pads under the Lifree and Charmnap brand.
Featured Stories
Before you consider Unicharm, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Unicharm wasn't on the list.
While Unicharm currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.